Research programme: NHE inhibitors - Medicure
Alternative Names: NHE inhibitors research programme - MedicureLatest Information Update: 24 May 2007
At a glance
- Originator Medicure
- Class
- Mechanism of Action Sodium-hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 24 May 2007 Discontinued - Preclinical for Cardiovascular disorders in Canada (unspecified route)
- 24 Apr 2007 No development reported - Preclinical for Cardiovascular disorders in Canada (unspecified route)
- 10 Dec 2002 Preclinical trials in Cardiovascular disorders in Canada (unspecified route)